|
1
|
Mogensen CE and Schmitz O: The diabetic
kidney: From hyperfiltration and microalbuminuria to end-stage
renal failure. Med Clin North Am. 72:1465–1492. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Büyükkoçak S, Oztürk HS, Tamer MN, Kaçmaz
M, Çimen MYB and Durak I: Erythrocyte oxidant/antioxidant status of
diabetic patients. J Endocrinol Invest. 23:228–230. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bonnet F and Cooper ME: Potential
influence of lipids in diabetic nephropathy: Insights from
experimental data and clinical studies. Diabetes Metab. 26:254–264.
2000.PubMed/NCBI
|
|
4
|
Ahn JH, Yu JH, Ko SH, Kwon HS, Kim DJ, Kim
JH, Kim CS, Song KH, Won JC, Lim S, et al: Taskforce Team of
Diabetes Fact Sheet of the Korean Diabetes Association: Prevalence
and determinants of diabetic nephropathy in Korea: Korea national
health and nutrition examination survey. Diabetes Metab J.
38:109–119. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mima A: Inflammation and oxidative stress
in diabetic nephropathy: New insights on its inhibition as new
therapeutic targets. J Diabetes Res. 2013:2485632013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wada J and Makino H: Inflammation and the
pathogenesis of diabetic nephropathy. Clin Sci (Lond). 124:139–152.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Duran-Salgado MB and Rubio-Guerra AF:
Diabetic nephropathy and inflammation. World J Diabetes. 5:393–398.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jian W, Peng W, Xiao S, Li H, Jin J, Qin
L, Dong Y and Su Q: Role of serum vaspin in progression of type 2
diabetes: A 2-year cohort study. PLoS One. 9:e947632014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Šenolt L, Polanská M, Filková M, Cerezo
LA, Pavelka K, Gay S, Haluzík M and Vencovský J: Vaspin and
omentin: New adipokines differentially regulated at the site of
inflammation in rheumatoid arthritis. Ann Rheum Dis. 69:1410–1411.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Phalitakul S, Okada M, Hara Y and Yamawaki
H: Vaspin prevents TNF-α-induced intracellular adhesion molecule-1
via inhibiting reactive oxygen species-dependent NF-κB and PKCθ
activation in cultured rat vascular smooth muscle cells. Pharmacol
Res. 64:493–500. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Karbek B, Bozkurt NC, Topaloglu O, Aslan
MS, Gungunes A, Cakal E and Delibasi T: Relationship of vaspin and
apelin levels with insulin resistance and atherosclerosis in
metabolic syndrome. Minerva Endocrinol. 39:99–105. 2014.PubMed/NCBI
|
|
12
|
Molitch ME, DeFronzo RA, Franz MJ, Keane
WF, Mogensen CE and Parving HH; American Diabetes Association, :
Diabetic nephropathy. Diabetes Care. 26 Suppl 1:S94–S98. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Giannakopoulos B, Gao L, Qi M, Wong JW, Yu
DM, Vlachoyiannopoulos PG, Moutsopoulos HM, Atsumi T, Koike T, Hogg
P, et al: Factor XI is a substrate for oxidoreductases: Enhanced
activation of reduced FXI and its role in antiphospholipid syndrome
thrombosis. J Autoimmun. 39:121–129. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Alzahrani SH and Ajjan RA: Coagulation and
fibrinolysis in diabetes. Diab Vasc Dis Res. 7:260–273. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Henry ML, Davidson LB, Wilson JE, McKenna
BK, Scott SA, McDonagh PF and Ritter LS: Whole blood aggregation
and coagulation in db/db and ob/ob mouse models of type 2 diabetes.
Blood Coagul Fibrinolysis. 19:124–134. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun X, Zhou X and Yan H: Hypercoagulation
aggravates renal dysfunction in patient with diabetic nephropathy.
Zhonghua Xue Ye Xue Za Zhi. 22:476–477. 2001.(In Chinese).
PubMed/NCBI
|
|
17
|
Patrassi GM, Martinelli S, Picchinenna A
and Girolami A: Contact phase of coagulation in diabetes mellitus
after aspirin administration. Folia Haematol Int Mag Klin Morphol
Blutforsch. 112:333–338. 1985.PubMed/NCBI
|
|
18
|
Patrassi GM, Vettor R, Padovan D and
Girolami A: Contact phase of blood coagulation in diabetes
mellitus. Eur J Clin Invest. 12:307–311. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen VM and Hogg PJ: Allosteric disulfide
bonds in thrombosis and thrombolysis. J Thromb Haemost.
4:2533–2541. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Emsley J, McEwan PA and Gailani D:
Structure and function of factor XI. Blood. 115:2569–2577. 2010.
View Article : Google Scholar : PubMed/NCBI
|
